- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Advanced Nonhematological Malignancies
Total 6996 results
-
Cornerstone PharmaceuticalsCompletedLymphoma | Metastatic Cancer | Advanced Cancer | Solid Tumors | Advanced MalignanciesUnited States, Canada
-
Hangzhou DAC Biotechnology Co., Ltd.Not yet recruitingAdvanced Solid Tumors | Hematological Malignancies
-
Antengene Discovery LimitedRecruitingAdvanced Solid Tumors | Hematological MalignanciesAustralia
-
Wake Forest University Health SciencesCompleted
-
Novartis PharmaceuticalsCompletedCancer Patients With Advanced Solid Tumors Including Lymphoma or Chronic Hematological MalignanciesUnited States
-
Novartis PharmaceuticalsActive, not recruitingAdvanced Malignancies That Harbor IDHR132 MutationsBelgium, Germany, Spain, Canada, Australia, United States, Netherlands, Singapore
-
Millennium Pharmaceuticals, Inc.CompletedSmall Cell Lung Cancer | Non-Small Cell Lung Cancer | Metastatic Breast Cancer | Head and Neck Squamous Cell Carcinoma | Gastroesophageal Adenocarcinoma | Advanced Nonhematological MalignanciesUnited States
-
Jiangsu HengRui Medicine Co., Ltd.307 Hospital of PLA; Peking University Cancer Hospital & InstituteCompletedAdvanced Solid MalignanciesChina
-
AstraZenecaMedImmune LLCCompletedBlood Cancer | Advanced B Cell MalignanciesJapan
-
Washington University School of MedicineAclaris Therapeutics, Inc.WithdrawnAdvanced Solid Tumor | Advanced Solid Tumor MalignanciesUnited States
-
4SC AGCompletedAdvanced Hematologic MalignanciesGermany
-
Incyte CorporationCompletedAdvanced MalignanciesUnited States
-
Shanghai Junshi Bioscience Co., Ltd.Iqvia Pty Ltd; TopAlliance Biosciences, Inc.Active, not recruitingAdvanced MalignanciesUnited States
-
Centre Hospitalier Universitaire de BesanconCentre Hospitalier Universitaire Saint Antoine, Paris; Centre de Lutte Contre... and other collaboratorsCompletedAdvanced Cancer | EthicsFrance
-
Novartis PharmaceuticalsTerminatedAdvanced MalignanciesTaiwan, Netherlands, Italy, Korea, Republic of, Japan, United States, Switzerland, Canada, Singapore
-
Shanghai Yuyao Biotech Co., Ltd.RecruitingAdvanced Solid Tumor | Hematological MalignancyChina
-
Helsinki University Central HospitalRecruitingSolid Tumor | Advanced Cancer | Haematological MalignancyFinland
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Metastatic Melanoma | Advanced Non-hematologic MalignanciesUnited States
-
Boston PharmaceuticalsCompletedAdvanced Nonhaematologic MalignanciesUnited States, Korea, Republic of, Taiwan, France, Hong Kong, Belgium, Spain
-
Curon Biopharmaceutical (Australia) Co Pty LtdNovotech (Australia) Pty LimitedNot yet recruitingMetastatic Solid Tumor | Hematologic Malignancies | Locally Advanced Solid Tumor
-
AbbVieCompletedCancer | Advanced Solid Tumors | Hematologic MalignanciesUnited States, Japan, Netherlands, Spain
-
Charite University, Berlin, GermanyUniversity of LeipzigUnknownAcute Myeloid Leukemias | Advanced Hematological Malignancies | Indication for Allogeneic Stem Cell Transplantation | no HLA-identical Donor AvailableGermany
-
Incyte CorporationTerminatedMetastatic Cancer | Solid Tumors | Advanced MalignanciesUnited States, United Kingdom, Spain
-
University of UtahElevar TherapeuticsTerminatedUrothelial Carcinoma | Advanced Malignancies | Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma | MSI-H or dMMR Solid TumorsUnited States
-
PfizerActive, not recruitingOvarian Cancer | NSCLC | Solid Tumors | Urothelial Cancer | Advanced MalignanciesHungary, Spain, United States, Canada, Taiwan, Japan, Serbia, Italy, New Zealand, Australia, Mexico, Russian Federation, United Kingdom, France, Korea, Republic of, Belgium, Poland, Denmark, Israel
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Solid Tumors | Hematologic MalignanciesUnited States
-
AstraZenecaRecruitingAdvanced Solid MalignanciesUnited States, Korea, Republic of, Spain, Australia, Sweden, Germany, United Kingdom
-
SingHealth PolyclinicsCompletedAdvanced Medical Directive, a Legal Document Signed in Advance to State Healthcare PreferencesSingapore
-
Institut Cancerologie de l'OuestRecruitingRelapsed Hematologic Malignancy | Advanced or Metastatic Solid TumorFrance
-
Calithera Biosciences, IncCompletedAdvanced Solid Tumor and Lymphoma MalignanciesUnited States, Spain, Italy, United Kingdom
-
Kiromic, Inc.TerminatedCancer | Progressive Solid Malignancies | Refractory Solid MalignanciesUnited States
-
AstraZenecaCompletedAdvanced Solid Malignancies | Malignant LymphomaUnited Kingdom, Japan
-
InnoPharmax Inc.CompletedAdvanced Solid Malignancies | Malignant LymphomasTaiwan
-
Curon Biopharmaceutical (Australia) Co Pty LtdNovotech (Australia) Pty LimitedTerminatedRelapsed Lymphoid Malignancies | Refractory Lymphoid MalignanciesAustralia
-
M.D. Anderson Cancer CenterTerminatedFatigue | Advanced Cancer | Hematologic MalignancyUnited States
-
Cristina GasparettoAgilent Technologies, Inc.Active, not recruitingLymphoid Malignancies | Myeloid MalignanciesUnited States
-
AstraZenecaCompletedAdvanced Solid Malignancies | Breast Cancer - ER+, HER2 - | Breast Cancer - ER+, HER2-, PIK3CA Gene MutationUnited States, United Kingdom
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingTotal Exenteration | Anterior or Posterior Pelvic Exenteration | Gynecologic Malignancies | Colorectal Malignancies | Urologic MalignanciesUnited States
-
Incyte Biosciences International SàrlCompletedMetastatic Cancer | Advanced MalignanciesUnited States
-
Beijing InnoCare Pharma Tech Co., Ltd.Active, not recruitingPart 1:r/r B-cell Malignancies | Part 2:B-cell MalignanciesUnited States, Poland, Israel, Ukraine
-
Tel-Aviv Sourasky Medical CenterMeir Medical Center; Max Planck Institute for Infection BiologyUnknownPediatric Solid Malignancies | Pediatric Hematological MalignanciesIsrael
-
Regeneron PharmaceuticalsSanofiCompletedMalignanciesUnited States, Korea, Republic of, Australia, Ireland, United Kingdom
-
MEI Pharma, Inc.Quotient ClinicalCompleted
-
Pathway Therapeutics, Inc.Completed
-
AgennixTerminatedMalignanciesUnited States
-
Xiao ChenRecruitingHepatic MalignanciesChina
-
Gilead SciencesCompletedMyeloid MalignanciesUnited States, Australia, United Kingdom
-
Zhujiang HospitalGuangzhou BRCompletedHepatobiliary MalignanciesChina
-
Gilead SciencesTerminatedLymphoid MalignanciesNetherlands
-
Southwest Hospital, ChinaUnknown